loading
loading
Sudeep Pharma Q2 FY27 results: Net profit rises nearly 13% to ₹52 crore, revenue up 21% - Edited byAjay Vaishnav - Published OnOct 28, 2026 | 19:46 IST - Last Updated OnOct 28, 2026 | 19:46 IST Sudeep Pharma reported a 12.7% rise in Q2 net profit to ₹52 crore, with revenue increasing 20.9% to ₹197 crore and EBITDA growing 32% to ₹73.2 crore. Sudeep Pharma reported a 12.7% year-on-year increase in net profit to ₹52 crore for the second quarter of the financial year 2026-27, compared with ₹45.7 crore in the corresponding quarter of the previous year. The company's revenue increased 20.9% year-on-year to ₹197 crore from ₹163 crore in the year-ago quarter. Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 32% to ₹73.2 crore from ₹55.5 crore. Sudeep Pharma's EBITDA margin improved to 37.2% in the September quarter, compared with 34.1% in the corresponding period last year, marking an expansion of 310 basis points. Sudeep Pharma Q2 Results: Net Profit Rises 12.7% Sudeep Pharma's net profit increased 12.7% year-on-year to ₹52 crore in the July-September quarter of FY27, compared with ₹45.7 crore in the corresponding quarter of the previous financial year. The increase in net profit came alongside double-digit growth in revenue and EBITDA, indicating an improvement in the company's financial performance during the quarter. Sudeep Pharma Q2 Results: Revenue Grows 20.9% The company's revenue rose 20.9% year-on-year to ₹197 crore in the September quarter, against ₹163 crore in the corresponding period last year. The growth reflected an increase in revenue from the company's business operations. Investors will monitor demand trends and the company's ability to sustain revenue growth in the coming quarters. Sudeep Pharma Q2 Results: EBITDA Rises 32%, Margin Expands Sudeep Pharma's EBITDA increased 32% year-on-year to ₹73.2 crore in the second quarter of FY27, compared with ₹55.5 crore in the year-ago period. The EBITDA margin expanded to 37.2% from 34.1%, marking an improvement of 310 basis points. EBITDA growth outpaced revenue growth during the quarter, while the improvement in margin indicated stronger operating profitability. Sudeep Pharma Share Price Sudeep Pharma shares opened at ₹1,030 and closed at ₹1,119, according to the share price figures provided. The stock's 52-week high stands at ₹1,378, while its 52-week low is ₹524.05. About Sudeep Pharma Incorporated in 1989, Sudeep Pharma is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
document fetched 2026-10-29 03:03 · canonical https://cnbctv18.com/market/earnings/sudeep-pharma-q2-fy27-results-net-profit-rises-12-7-pc-to-rs52-crore-revenue-up-20-9-pc-20021655.htm